Seven Indian Pharma Players Race To Develop COVID-19 Vaccine
India News | Press Trust of India | Sunday July 19, 2020
At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally.
Government Restricts Export Of Some Pharma Ingredients, Drugs
Business | Reuters | Tuesday March 3, 2020
Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
India News | Press Trust of India | Sunday May 13, 2018
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
India News | Nupur Acharya, Bloomberg | Tuesday May 16, 2017
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
US Pharma Sector Demands Keeping India In Patent Violator List
Business | Press Trust of India | Tuesday February 14, 2017
Among the key issues of concern for the US pharma sector in India are unpredictable IP environment, high tariffs and taxes on medicines among others.
Pharma Stocks Hit After Trump's 'Getting Away With Murder' Comment
Business | Thursday January 12, 2017
Dr Reddy's Laboratories, Sun Pharmaceutical Industries and Lupin were the most hit, suffering losses of up to 3 per cent.
Indian Pharma's Focus On Acquisitions To Limit Deleveraging: Fitch
Business | Press Trust of India | Tuesday November 15, 2016
New Delhi: In line with global trends in thepharmaceuticals sector, the focus of domestic drug firms on acquisitionsto consolidate their position will limit deleveraging for thetime being, rating agency Fitch has said. "The ongoing focus of the top Indian pharma companies' onselective acquisitions to limit deleveraging over the shortterm," Fitch...
Aurobindo Pharma Gains On Buzz Of Big UK Acquisition
Business | NDTV Profit Team | Monday August 29, 2016
Aurobindo Pharma shares gained over 1 per cent on Monday after a news report said that the Indian pharma company is a frontrunner to buy Teva Pharmaceutical's UK business, which had revenue of around $300 million last fiscal.
PM Modi Likely To Chair Meeting On FDI Roadmap On Tuesday: Report
Business | Press Trust of India | Sunday June 19, 2016
The Prime Minister's Office has convened a meeting on June 21 to deliberate upon a roadmap for further easing FDI norms to attract more foreign investment.
Pharma Stocks Look Attractive After Correction: Chintan Haria
Business | NDTV Profit Team | Tuesday June 7, 2016
The fund manager said Indian pharma companies have established their strong foothold and they will continue to grow as far as generics are concerned. Most of the pharma companies have strong balance sheet as well, he added.
Strides Shasun Launches up to Rs 1,500 crore Share Sale : Report
Business | Thomson Reuters | Friday December 18, 2015
Indian pharmaceutical company Strides Shasun limited has launched a share sale to raise funds up to Rs1,500 crore, IFR reported on Friday, citing a source close to the transaction.
Cipla Jumps on Announcement of New Algerian Venture
Business | Friday February 13, 2015
The Indian pharma company's wholly owned subsidiary, Cipla (EU) Limited, will hold a 40 per cent stake in the joint venture, while the remainder will be held by a Biopharm-led Algerian consortium. The joint venture is expected to make an investment of up to $15 million in the construction of a manufacturing facility.
Generic Opportunities to Drive Indian Pharma Sector Growth: Icra
Business | Wednesday August 20, 2014
With many drugs going off patent in the US, Indian pharma companies would continue to experience strong growth in American market, credit rating agency Icra has said.
US generic drug fee relief plan may benefit Indian companies
Business | Sunday December 15, 2013
With the US Food and Drug Administration proposing to hike the fees for generic drug-makers for next fiscal, concerns had been raised on the financial burden that the one-size-fits-all fee structure creates issues for the smaller units, which typically face cash crunch problems.
Indian pharma company in dock over fake medicines in Ghana
Business | Thursday October 3, 2013
Food and Drug Authority Ghana said in a statement that officials of Bliss GVS Pharma of India and Ghanaian drug maker Tobinco Pharmaceuticals have apologised to it for importing 'fake malaria medicine' to Ghana to treat malaria in children.
"Pandemic Has Shown Indian Pharma Asset For World": PM At Global Event
Jul 9, 2020
Pharma Stocks Still Attractive: Birla Sun Life Insurance
Mar 30, 2015
Faster ANDA Approval
Mar 20, 2015
Indian pharma needs to reinvent?
Aug 18, 2009
Pharma cos targetting niche products to stay fit
Jan 19, 2009
Sun Pharma to buy Taro for $454 mn
May 22, 2007
Pharma companies doing robust business
Jan 18, 2007
Pharma cos seek to share R&D with MNCs
Jul 31, 2006
Pharma cos seek quality control executives
Mar 13, 2006
Seven Indian Pharma Players Race To Develop COVID-19 Vaccine
India News | Press Trust of India | Sunday July 19, 2020
At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally.
Government Restricts Export Of Some Pharma Ingredients, Drugs
Business | Reuters | Tuesday March 3, 2020
Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
India News | Press Trust of India | Sunday May 13, 2018
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
India News | Nupur Acharya, Bloomberg | Tuesday May 16, 2017
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
US Pharma Sector Demands Keeping India In Patent Violator List
Business | Press Trust of India | Tuesday February 14, 2017
Among the key issues of concern for the US pharma sector in India are unpredictable IP environment, high tariffs and taxes on medicines among others.
Pharma Stocks Hit After Trump's 'Getting Away With Murder' Comment
Business | Thursday January 12, 2017
Dr Reddy's Laboratories, Sun Pharmaceutical Industries and Lupin were the most hit, suffering losses of up to 3 per cent.
Indian Pharma's Focus On Acquisitions To Limit Deleveraging: Fitch
Business | Press Trust of India | Tuesday November 15, 2016
New Delhi: In line with global trends in thepharmaceuticals sector, the focus of domestic drug firms on acquisitionsto consolidate their position will limit deleveraging for thetime being, rating agency Fitch has said. "The ongoing focus of the top Indian pharma companies' onselective acquisitions to limit deleveraging over the shortterm," Fitch...
Aurobindo Pharma Gains On Buzz Of Big UK Acquisition
Business | NDTV Profit Team | Monday August 29, 2016
Aurobindo Pharma shares gained over 1 per cent on Monday after a news report said that the Indian pharma company is a frontrunner to buy Teva Pharmaceutical's UK business, which had revenue of around $300 million last fiscal.
PM Modi Likely To Chair Meeting On FDI Roadmap On Tuesday: Report
Business | Press Trust of India | Sunday June 19, 2016
The Prime Minister's Office has convened a meeting on June 21 to deliberate upon a roadmap for further easing FDI norms to attract more foreign investment.
Pharma Stocks Look Attractive After Correction: Chintan Haria
Business | NDTV Profit Team | Tuesday June 7, 2016
The fund manager said Indian pharma companies have established their strong foothold and they will continue to grow as far as generics are concerned. Most of the pharma companies have strong balance sheet as well, he added.
Strides Shasun Launches up to Rs 1,500 crore Share Sale : Report
Business | Thomson Reuters | Friday December 18, 2015
Indian pharmaceutical company Strides Shasun limited has launched a share sale to raise funds up to Rs1,500 crore, IFR reported on Friday, citing a source close to the transaction.
Cipla Jumps on Announcement of New Algerian Venture
Business | Friday February 13, 2015
The Indian pharma company's wholly owned subsidiary, Cipla (EU) Limited, will hold a 40 per cent stake in the joint venture, while the remainder will be held by a Biopharm-led Algerian consortium. The joint venture is expected to make an investment of up to $15 million in the construction of a manufacturing facility.
Generic Opportunities to Drive Indian Pharma Sector Growth: Icra
Business | Wednesday August 20, 2014
With many drugs going off patent in the US, Indian pharma companies would continue to experience strong growth in American market, credit rating agency Icra has said.
US generic drug fee relief plan may benefit Indian companies
Business | Sunday December 15, 2013
With the US Food and Drug Administration proposing to hike the fees for generic drug-makers for next fiscal, concerns had been raised on the financial burden that the one-size-fits-all fee structure creates issues for the smaller units, which typically face cash crunch problems.
Indian pharma company in dock over fake medicines in Ghana
Business | Thursday October 3, 2013
Food and Drug Authority Ghana said in a statement that officials of Bliss GVS Pharma of India and Ghanaian drug maker Tobinco Pharmaceuticals have apologised to it for importing 'fake malaria medicine' to Ghana to treat malaria in children.
"Pandemic Has Shown Indian Pharma Asset For World": PM At Global Event
Jul 9, 2020
Pharma Stocks Still Attractive: Birla Sun Life Insurance
Mar 30, 2015
Faster ANDA Approval
Mar 20, 2015
Indian pharma needs to reinvent?
Aug 18, 2009
Pharma cos targetting niche products to stay fit
Jan 19, 2009
Sun Pharma to buy Taro for $454 mn
May 22, 2007
Pharma companies doing robust business
Jan 18, 2007
Pharma cos seek to share R&D with MNCs
Jul 31, 2006
Pharma cos seek quality control executives
Mar 13, 2006
................................ Advertisement ................................
................................ Advertisement ................................
